Ask AI
ProCE Banner Activity

From Numbers to Nuance in Hyperlipidemia: Expert Insights on Frequently Asked Questions About ASCVD Prevention and Lipid Management

Clinical Thought

An expert in cardiology answers your frequently asked questions about contemporary hyperlipidemia management—from enhanced screening and risk stratification with lipoprotein(a) to treatment strategies employing nonstatin lipid-lowering therapies to further lower LDL cholesterol and prevent atherosclerotic cardiovascular disease.

Released: December 30, 2025

Continue Activity View Activity

Share

Provided by

Provided by Partners for Advancing Clinical Education (Partners) in partnership with the Academy of Physician Associates in Cardiology (APAC).

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Academy of Physician Associates in Cardiology (APAC)

ProCE Banner

Target Audience

This activity is intended for cardiology-focused nurse practitioners, physician associates, clinical nurse specialists, and advanced degree nurses.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Plan individualized, guideline-recommended lipid-lowering treatment strategies using nonstatin or combination therapies to improve patient outcomes

  • Design comprehensive, interprofessional, patient-centered care plans for individuals with or at risk for ASCVD that ensure optimal coordination and access for underserved patients

  • Educate patients and caregivers on the clinical rationale for nonstatin or combination therapies to treat hyperlipidemia, addressing concerns on side effects and providing strategies to promote compliance

Disclosure

Primary Author

Laura Ross, PA-C, MPAS, CLS, DipACLM, AACC, has no relevant financial relationships to disclose.